Cavion to Present Results of Phase 2 Essential Tremor Clinical Trial in Platform Presentation at the American Academy of Neurology
CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 24, 2019--Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for…
